Arvinas, Inc. (ARVN)
NASDAQ: ARVN · IEX Real-Time Price · USD
28.52
-0.37 (-1.28%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Arvinas Employees
Arvinas had 445 employees as of December 31, 2023. The number of employees increased by 30 or 7.23% compared to the previous year.
Employees
445
Change (1Y)
30
Growth (1Y)
7.23%
Revenue / Employee
$160,225
Profits / Employee
-$797,303
Market Cap
1.95B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 445 | 30 | 7.23% |
Dec 31, 2022 | 415 | 135 | 48.21% |
Dec 31, 2021 | 280 | 101 | 56.42% |
Dec 31, 2020 | 179 | 46 | 34.59% |
Dec 31, 2019 | 133 | 50 | 60.24% |
Dec 31, 2018 | 83 | 14 | 20.29% |
Dec 31, 2017 | 69 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
National HealthCare | 13,123 |
Amphastar Pharmaceuticals | 1,761 |
Novavax | 1,543 |
Alignment Healthcare | 1,536 |
NovoCure | 1,453 |
LeMaitre Vascular | 630 |
Recursion Pharmaceuticals | 500 |
Immunocore Holdings | 497 |
ARVN News
- 27 days ago - Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer - GlobeNewsWire
- 4 weeks ago - Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2 - GlobeNewsWire
- 5 weeks ago - Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. - GlobeNewsWire
- 6 weeks ago - Arvinas to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress - GlobeNewsWire
- 2 months ago - Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) - GlobeNewsWire
- 2 months ago - Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress - GlobeNewsWire
- 2 months ago - Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire